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Patients with chronic inﬂ  ammation commonly complain about 
early satiety and loss of appetite, which in the case of cancerous 
and HIV-positive individuals can accompany dramatic weight loss 
known as cachexia (Laviano et al., 2003; Tisdale, 2009). The micro-
environment surrounding tumoral cells, as well as tumoral cells 
themselves, are thought to produce pro-inﬂ  ammatory cytokines 
(Seruga et al., 2008), and tumor-bearing rodents frequently show 
anorexia (Bernstein and Fenner, 1983; Bernstein et al., 1985; Plata-
Salaman et al., 1998; Meguid et al., 1999; Varma et al., 2001). It 
is important to mention that cachexia and anorexia are distinct 
phenomena which do not necessarily coexist (depending on tumor 
size and location, age); however, patients with both conditions 
show the worst prognosis (Laviano et al., 2003; Tisdale, 2009). Of 
note, the reduction of appetite observed in cancer patients does 
not solely result from inﬂ  ammation but also from psychological 
distress and anticancer therapies (i.e., interferons) (Capuron et al., 
2002). Unfortunately, efﬁ  cient therapies to alleviate  inﬂ  ammation-
 associated anorexia are currently limited and, therefore,  investigating 
their underlying mechanisms is truly relevant in the ﬁ  ght against 
cancer- and infection-related loss of appetite.
HOW DO PRO-INFLAMMATORY CYTOKINES ALTER NEURAL 
ACTIVITY?
THE NEURAL PATHWAY
Communication from the periphery to the brain involves, in addi-
tion to endocrine mechanisms, cranial and spinal nerves innerva-
tions. Virtually all tissues are innervated by a dense network of 
cranial and/or spinal sensory terminals which are capable of detect-
ing a wide range of physiological signals. It has been shown that 
peripheral sensory neurons can sense pro-inﬂ  ammatory factors. 
Receptors and binding sites for IL-1β and prostaglandin E2 (PGE2), 
for instance, have been reported in vagal, spinal, and trigeminal 
INTRODUCTION: WHEN INFLAMMATION SUPPRESSES 
APPETITE
Inﬂ  ammation-associated anorexia refers to the reduction of food 
intake observed during acute and chronic inﬂ  ammatory states in both 
men and animals. It is well established that laboratory animals reduce 
their food intake in response to the peripheral administration of pro-
inﬂ  ammatory cytokines such as interleukin-1β (IL-1β) or stimulants 
of the release of cytokines such as lipopolysaccharide (LPS). Notably, 
the administration of LPS reduces meals frequency, while that of IL-
1β reduces both meals frequency and size (Langhans et al., 1993). 
LPS and IL-1β also induce an aversion for a novel food or a sucrose 
solution (Tazi et al., 1988; Langhans et al., 1990; Weingarten et al., 
1993; Bauer et al., 1995; Goehler et al., 1995), inhibit food- motivated 
behavior (Bret-Dibat et al., 1995; Kent et al., 1996), render the con-
sumption of sucrose less pleasurable (anhedonia) (Yirmiya, 1996; 
Borowski et al., 1998; Merali et al., 2003), and increase the preference 
for carbohydrates and avoidance for aversive substances (Aubert et al., 
1995; Cross-Mellor et al., 2004; Aubert and Dantzer, 2005). Although 
appetite (and thus anorexia) cannot be directly evaluated in animals, 
most researchers have been using the term of “anorexia” in animals 
based on the assumption that reduced appetite accounts for the reduc-
tion of food intake that follows the administration of either cytokines 
or LPS (Konsman and Dantzer, 2001). Inﬂ  ammation-associated ano-
rexia is acknowledged to help maintaining body integrity in face of 
infections and physical injuries (Hart, 1988; Exton, 1997). In essence, 
it is part of a process of energy repartition involving reducing activities 
such as food seeking and digestion which would otherwise consume 
up the energy needed to develop immune responses. There is also 
some evidence that food deprivation per se prolongs the survival of 
mice infected with Listeria (Wing and Young, 1980), a phenomenon 
that possibly involves the reduction of the levels of micronutrients 
required for bacterial proliferation (Weinberg, 1984).
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involves their direct action on the central nervous system. For 
instance, the intracerebroventricular administration of a small dose 
of LPS or IL-1β is sufﬁ  cient to induce anorexia (Kent et al., 1992; 
Yao et al., 1999). Other cytokines such as tumor necrosis factor 
alpha and interleukin-6 similarly reduce feeding when centrally 
administered (Kapas and Krueger, 1992; Fantino and Wieteska, 
1993; Plata-Salaman, 1996; Plata-Salaman et al., 1996; Sonti et al., 
1996). IL-1β orchestrates the expression of other cytokines in the 
brain (Laye et al., 1994; Mingam et al., 2008a), and more impor-
tantly, the blockade of cerebral IL-1β receptor by its endogenous 
antagonist IL-1ra partially prevents LPS-induced anorexia (Laye 
et al., 2000). The action of pro-inﬂ  ammatory cytokines directly on 
the central nervous system is referred in the literature to as “the 
humoral pathway” (Figure 1).
It initially seemed surprising that cytokines are capable of 
acting on the central nervous system when considering that the 
blood-brain barrier prevents most blood-borne pro-inﬂ  ammatory 
factors and immune cells to access the brain. In fact, the central 
nervous system does contain immunocompetent cells which are 
fully capable of detecting pathogen-associated molecular pat-
terns and of producing pro-inﬂ  ammatory factors in response to 
injury and inﬂ  ammatory challenges (Rivest, 2003). Furthermore, 
specialized areas of the brain known as circumventricular organs 
are devoid of a blood-brain barrier, and as such are readily acces-
sible to systemic pathogen-associated molecular patterns such as 
LPS (Rivest, 2003). The mammalian brain contains four known 
circumventricular organs which are the AP, the median eminence, 
the subfornical organ, and the organum vasculosum of the lam-
ina terminalis. Brain cells capable of producing IL-1β have been 
identiﬁ  ed as perivascular macrophages, microglial cells and mac-
rophages in the choroid plexus and meninges (van Dam et al., 
1992, 1995; Buttini and Boddeke, 1995; Konsman et  al., 1999; 
Goehler et al., 2006). Numerous studies have reported the pres-
ence of IL-1 binding sites and receptors (IL-1R) prominently in 
brain endothelial cells (Farrar et al., 1987; Takao et al., 1990; Ban 
et al., 1991; Cunningham et al., 1992; Ericsson et al., 1995; French 
et al., 1999; Konsman et al., 2004), choroid plexus, and to a lesser 
extent in some neurons of the hippocampus, arcuate nucleus and 
amygdala. Recently, Ching et al. (2007) elegantly demonstrated 
using a genetic approach that the selective deletion of IL-1R in 
brain endothelial cells prevents intravenous IL-1-induced fever 
and hypothalamo–pituitary–adrenal axis stimulation (this study, 
however, did not survey food intake). Another study showed that 
the pharmacological inhibition of nuclear factor kappa B (NF-kB), 
a transcription factor downstream of IL-1 signaling pathway in 
endothelial cells, attenuates IL-1-induced anorexia (Nadjar et al., 
2005). Similarly, LPS-induced anorexia is blunted in mice lacking 
MyD88 (Myeloid differentiation primary response gene 88) (Wisse 
et al., 2007), which is a critical molecular component of both IL-1 
and LPS signaling in perivascular and endothelial cells (Gosselin 
and Rivest, 2008).
All the aforementioned data demonstrate that LPS and IL-1β 
signaling in brain endothelial cells (and possibly perivascular cells) 
plays a critical role in inﬂ  ammation-associated anorexia. However, 
these data do not explain how LPS or IL-1β ultimately change 
the activity of neurons involved in feeding. The production and 
release of PGE2 within the intracranial cavity is promoted by the 
  sensory neurons (Matsumura et al., 1995; Goehler et al., 1997; Ek 
et al., 1998; Copray et al., 2001; Obreja et al., 2002; Patwardhan 
et al., 2008). Furthermore, electrophysiological studies demon-
strated that both IL-1β and PGE2 rapidly depolarize vagal sensory 
neurons (Niijima, 1996; Gaige et al., 2004; Snitsarev et al., 2007), 
as well as trigeminal and spinal sensory neurons (Pitchford and 
Levine, 1991; England et al., 1996; Binshtok et al., 2008; Takeda 
et al., 2008).
It is widely agreed that the action of pro-inﬂ  ammatory factors 
on peripheral sensory terminals plays a prominent role when an 
inﬂ  ammatory event is conﬁ  ned to a speciﬁ  c tissue. For example, 
trigeminal afferents that innervate the meninges are recruited upon 
inﬂ  ammation limited to the intracranial cavity (i.e., meningitis, 
migraine), and the application of a mixture of pro-inﬂ  ammatory 
agents on meninges sensory terminals induces profound feeding 
suppression in rats (Malick et al., 2001). More direct evidence of the 
involvement of the neural pathway in anorexia has been provided 
by experiments conducted in vagotomized animals. Rodents with 
bilateral subdiaphragmatic surgical vagotomy or chemical deaf-
ferentation (capsaicin) show attenuated anorexia and brain IL-1β 
expression in response to the intraperitoneal administration of 
LPS or IL-1β (Bret-Dibat et al., 1995; Laye et al., 1995; Sergeev and 
Akmaev, 2000) and are less sensitive to the aversive effects of periph-
eral IL-1β (Goehler et al., 1995). Likewise, vagotomy procedures 
attenuate anorexia in tumor-bearing rats (Bernstein, 1996).
The nucleus of the solitary tract (NTS) and the adjacent area 
postrema (AP) located in the dorso-caudal brainstem are the pri-
mary relays of vagal terminal ﬁ  elds in the central nervous system 
(Figure 1). The NTS also receives indirect projections from some 
trigeminal and spinal sensory neurons (Gamboa-Esteves et al., 2001; 
Craig, 2002; Burstein and Jakubowski, 2005). Glutamate serves as 
the main neurotransmitter in vagal afferents terminals in the NTS, 
and it has been shown that LPS administration induces glutamate 
release in the NTS (Lin et al., 1999). In fact, one study has shown that 
the peripheral administration of metabotropic glutamate receptor 
antagonists attenuates inﬂ  ammation- associated anorexia (Weiland 
et al., 2006), an effect that could possibly be explained by a reduc-
tion of vagal and/or spinal glutamatergic neurotransmission. The 
implication of the NTS in immune sensing is also demonstrated by 
neuroanatomical studies using the expression of c-fos as a marker 
of neuronal activation. Multiple investigators have reported robust 
c-fos expression in the NTS   subsequently to an   intraperitoneal 
inﬂ  ammation  (Wan et  al., 1993; Rivest and Laﬂ  amme,  1995; 
Sagar et al., 1995; Konsman et al., 2000; Ge et al., 2001). Similarly, 
tumor-bearing rats show c-fos expression in the NTS (Konsman 
and Blomqvist, 2005; Ruud and Blomqvist, 2007).
THE HUMORAL PATHWAY
In contrast with previously mentioned observations, several stud-
ies showed the intact anorectic effects of LPS and IL-1β in vagot-
omized animals (Schwartz et al., 1997; Porter et al., 1998; Wieczorek 
et al., 2005). The induction of c-fos in the NTS following either 
intravenous LPS or IL-1β is also preserved in vagotomized ani-
mals (Ericsson et al., 1997; Hermann et al., 2001), suggesting that 
an intact vagus nerve is not always required for the stimulation 
of NTS neurons in response to an immune challenge. Another 
mechanism by which pro-inﬂ  ammatory factors trigger anorexia 
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stimulation of IL-1R and LPS receptor positioned in cells forming 
the blood-brain barrier including endothelial cells, choroid plexus 
and meninges (Rivest, 1999; Ek et al., 2001; Konsman et al., 2004). 
In turn, PGE2 are thought to directly act on neurons important in 
feeding. In agreement with such a view, the central administration 
of PGE2 induces c-fos expression in brain sites directly comparable 
to that recruited by IL-1β (Lacroix et al., 1996). Additionally, it has 
been consistently shown that the pharmacological inhibition and 
the genetic deletion of enzymes synthesizing PGE2 reduce anorexia 
following peripheral LPS or IL-1β (Johnson et al., 2002; Lugarini 
FIGURE 1 | Neural circuitry implicated in inﬂ  ammation-associated 
anorexia and possible approaches to alleviate anorexia. The action of 
pro-inﬂ  ammatory cytokines and pathogen-associated molecular patterns on 
peripheral sensory neurons (neural pathway) and the blood-brain barrier 
(humoral pathway) leads to changes in the activity of key feeding-related brain 
sites distributed in the brainstem and hypothalamus. This neurobiological 
model predicts that inﬂ  ammation-associated anorexia can be modulated by 
several complementary approaches including to not limited to nutritional and 
pharmacological approaches. The most promising strategy to attenuate 
anorexia consists in modulating the melanocortin system by administrating 
orexigenic agents which are known to act on Arc neurons. Dotted lines 
represent the diffusion and action of factors implicated in the humoral 
pathway. EPs are connected to brain sites in which they are predominantly 
expressed. Abbreviations: Acb, rostral nucleus accumbens; Arc, arcuate 
nucleus; BBB, blood-brain barrier; BST, nucleus of the stria terminalis; CeA, 
central amygdala; CVOs, circumventricular organs; EP , prostaglandins 
receptors; IL -1, interleukin-1; LHA, lateral hypothalamus; LPS, 
lipopolysaccharide; PGE2, prostaglandins E2; PVN, nucleus of the 
paraventricular hypothalamus; pvt, paraventricular thalamus; lPB, lateral 
parabrachial nucleus; NTS, nucleus of the solitary tract.
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et al., 2002; Pecchi et al., 2006; Elander et al., 2007). According to 
the literature, PGE2 bind four known G proteins-coupled  receptors 
(EP1-4) which are abundantly expressed in the preoptic area, 
hypothalamus and hindbrain including the NTS (Zhang and Rivest, 
1999; Oka et al., 2000; Engblom et al., 2001) (Figure 1). Also, EP3 
has been recently implicated in the regulation of feeding since mice 
lacking this receptor develop hyperphagia (Sanchez-Alavez et al., 
2007). Finally, there is direct evidence that PGE2 can modulate the 
electrophysiological activity of PGE2-sensitive neurons in brain 
regions important in feeding such as the NTS. For example, the 
application of PGE2 in NTS preparation rapidly enhances gluta-
matergic transmission, while it reduces presynaptic vagal neuro-
transmission (Marty et al., 2008).
THE NEURAL CIRCUITS PRODUCING INFLAMMATORY-
ASSOCIATED ANOREXIA
VISCERO-SENSORY PATHWAYS
The regulation of appetite involves multiple internal and environ-
mental factors which are integrated in speciﬁ  c neuronal groups 
distributed across the neuraxis. The brainstem contributes to the 
short-term regulation of appetite in response to signals arising from 
the gut. Notably, early studies in decerebrate animals demonstrated 
that the brainstem is sufﬁ  cient to produce post-prandial satiety 
(Grill and Smith, 1988). Within the brainstem, the NTS plays an 
important role in the control of satiety and aversion by acting as 
viscero-sensory relays for gastrointestinal signals predominantly 
conveyed through the vagus nerve (Adachi et al., 1991; Schwartz, 
2000). As mentioned earlier, NTS neurons integrate signals origi-
nating from both the neural and humoral pathways (Figure 1), 
making this brain structure one of the most important site in 
mediating inﬂ  ammation-associated anorexia. The administration 
of IL-1 into the fourth ventricle, which provides cerebrospinal ﬂ  uid 
to the brainstem, is sufﬁ  cient to induce c-fos in NTS and, more 
importantly, a profound anorexia (DeBoer et al., 2009). Among 
NTS neurons known to be activated in response to LPS are neu-
rons producing glucagon-like peptide 1 (GLP-1) (Rinaman, 1999), 
a well-known anorectic peptide (Kinzig et al., 2002). Speciﬁ  cally, 
the pharmacological inhibition of GLP-1 receptor in the brainstem 
attenuates LPS-induced anorexia, suggesting that GLP-1-producing 
neurons directly contribute to anorexia (Grill et al., 2004).
NTS neurons activated in response to inﬂ  ammation send projec-
tions to the lateral parabrachial nucleus (lPB), bed nucleus of the 
stria terminalis (BST), central amygdala (CeA) and paraventricular 
nucleus of the hypothalamus (PVN) (Ericsson et al., 1994; Tkacs and 
Li, 1999; Buller and Day, 2002; Crane et al., 2003; Gaykema et al., 
2007) (Figure 1). The exact role of the aforementioned structures 
in feeding behavior remains understudied, however, it is known that 
these structures all receive visceral- and gustatory-related informa-
tion and are, individually or collectively, implicated in hypophagic 
behaviors such as stress-induced anorexia (Koob, 1999), satiety/aver-
sion (Reilly and Trifunovic, 2000; Sclafani et al., 2001; Ferreira et al., 
2006; Becskei et al., 2007), food avoidance and preference (Kelley 
et al., 2003; Ferreira et al., 2006). Yet the direct implication of these 
structures in anorexia will require further testing.
The PVN deserves a special mention. Indeed, lesions of the 
PVN increase food intake (Gold, 1970; Choi and Dallman, 1999), 
indicating the pivotal role of this structure in reducing feeding. 
In addition, we previously showed that the expression of c-fos in 
the PVN positively correlates with the intensity of anorexia after 
LPS administration (Gautron et al., 2005). While it is admitted 
that corticotropin-releasing hormone (CRH)-producing neurons 
of the PVN control the hypothalamo–pituitary–adrenal axis, they 
are also good candidates to contribute to the anorectic effect of 
inﬂ  ammation in view of the facts that CRH exerts anorectic effects 
(Dunn and Berridge, 1990) and the immunoneutralization of 
CRH attenuates IL-1-induced anorexia (Uehara et  al., 1989). 
However, CRH is produced in widespread brain sites and the con-
tribution of PVN CRH-expressing neurons in anorexia relative 
to other sites has not been veriﬁ  ed. Cocaine- and amphetamine-
regulated transcript (CART) is another anorectic peptide pro-
duced in the PVN (Kristensen et al., 1998). Interestingly enough, 
CART-  expressing neurons of the PVN are activated in response 
to LPS (Fuzesi et al., 2008), number of which also innervate the 
NTS. Together, it indicates that inﬂ  ammation-associated anorexia 
presumably engages reciprocally connected neuronal groups in 
the NTS and PVN (Figure 1).
THE MELANOCORTIN SYSTEM
The melanocortin system tightly regulates appetite downstream 
of hormonal indicators of energy status such as leptin, insulin 
and ghrelin. The arcuate nucleus of the hypothalamus (Arc) con-
tains pro-opiomelanocortin neurons (POMC) which produce 
the anorectic peptides alpha-melanocyte stimulating hormone 
(α-MSH) and CART. Importantly, α-MSH is an endogenous ago-
nist of the melanocortin-4 receptor (MC4R) which is a major regu-
lator of food intake (Seeley et al., 2004; Cone, 2006). Uniquely, the 
Arc also contains neurons which produce the orexigenic peptides 
agouti-related protein (AgRP) and neuropeptide Y (NPY). AgRP 
is an endogenous MC4R antagonist. Persuasive evidence has estab-
lished that the activity of both populations of neurons is oppositely 
regulated by the humoral signals leptin and ghrelin (Seeley et al., 
2004). In fact, whereas leptin signaling in POMC neurons mediates 
its anorectic effects (Hill et al., 2008), ghrelin signaling in AgRP 
neurons promotes its stimulatory effects on appetite (Luquet et al., 
2007). Ultimately, these neurons project to a number of brain sites 
involved in feeding including the NTS, PVN, lateral hypothalamus 
and lPB to modulate their activity in face of changes in energy 
status (Figure 1).
Earlier studies reported increased plasma leptin levels in 
response to LPS in mice and rats (Sarraf et al., 1997; Faggioni 
et al., 1999; Finck and Johnson, 1999; Mastronardi et al., 2000), 
making leptin a potential candidate involved in inflammation-
associated anorexia. Moreover, the melanocortin system has 
been shown to be involved in acute and chronic inflammatory-
associated anorexia based on neuroanatomical (Sergeyev et al., 
2001; Reyes and Sawchenko, 2002; Borges et al., 2007; Scarlett 
et al., 2007), pharmacological (Huang et al., 1999; Wisse et al., 
2001), electrophysiological (Scarlett et al., 2007), and transgenic 
mice studies (Marks et al., 2001). However, parallel studies have 
challenged the role played by leptin and the melanocortin sys-
tem in anorexia by showing that intraperitoneal LPS does not 
elevate plasma leptin levels in rats (Giovambattista et al., 2000; 
Gautron et al., 2005; Spencer et al., 2007). In addition, leptin- 
and leptin receptor-deficient animals are still fully responsive 
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(a long chain ω-3 polyunsaturated fatty acid),  corticosteroids and 
progestrogens derivates (Mattox, 2005; Tisdale, 2006). Despite 
the fact they exert well documented anti-inﬂ  ammatory actions, 
these agents show only temporary beneﬁ  ts on appetite, numer-
ous side effects and their mechanism of actions on feeding 
remain unclear.
Nutritional approaches are not only necessary to prevent deﬁ  -
ciencies and reduce gastrointestinal upsets, but also to increase 
the survival time of cancer patients by reducing whole body 
inﬂ  ammation. For instance, a low fat and high ﬁ  bers diet has 
been shown to prolong the survival of women with breast can-
cer (Zhang et al., 1995; Pierce et al., 2007). Some studies also 
suggested that rats fed on ﬁ  sh oil (rich in long chain ω-3 poly-
unsaturated fatty acid) show reduced anorexia in response to 
IL-1 and tumor growth (Hellerstein et al., 1989; Goncalves et al., 
2006). In addition, the use of non-steroidal anti-inﬂ  ammatory 
drugs combined with a diet enriched in ω-3 can modestly improve 
appetite in cancer patients (Lundholm et al., 1994; Wigmore 
et al., 2000; Cerchietti et al., 2004; Jatoi et al., 2004). By contrast, 
other studies have failed to demonstrate any beneﬁ  cial effects of 
ω-3-enriched diets in LPS-treated mice and cancerous patients 
(Mingam et al., 2008b; Mazzotta and Jeney, 2009). Despite these 
contradictory results, considering the key role played by PGE2 
in immune-to-brain communication, therapeutic trials involving 
the manipulation of eicosanoids metabolism by pharmacological 
and nutritional means is considered a useful strategy to lower 
anorexia (Figure 1).
Once again, appetite is regulated both by internal and envi-
ronmental factors. Cancer patients are submitted to intense stress, 
and efforts to attenuate anorexia using anti-inﬂ  ammatory agents 
and nutrition may be in vain if their psychological distress is not 
addressed. In this regard, attention to the patient’s psychological 
well-being has been shown to help patients regaining interest for 
food (Holland et al., 1977). Presumably, one mechanism by which 
stress reduces appetite is by directly interfering with neural systems 
involved in feeding including POMC and CRH neurons (Koob, 
1999; Liu et al., 2007); another mechanism is by aggravating periph-
eral inﬂ  ammation (Gibb et al., 2008).
BLOCKING THE NEURAL PATHWAY
Agents that reduce the activity of vagal and/or spinal nerves such 
as anti-emetics and analgesics can also be used to treat cancer 
patients (Davis et al., 2006). While it is unclear whether sensory 
afferents can directly detect tumors, it has been proposed that 
reducing the activity of peripheral sensory afferents may result in 
augmented appetite in cancer. For example, the blockade of type 
3 serotonergic receptors (5-HT3R) improves the ability of cancer 
patients to enjoy food (Edelman et al., 1999). Binding sites for 
5-HT3R are abundant in the NTS/AP (Marazziti et al., 2001), but 
the receptor mRNA itself is found in the nodose ganglion and not 
the NTS/AP (Tecott et al., 1993; Morales and Wang, 2002). Thus, 
5-HT3R ligands act on receptors produced by vagal neurons and 
transported to their terminals located within the NTS and AP. 
These treatments in combination with adequate nutrition are use-
ful to alleviate nausea, pain and gastrointestinal tract discomfort 
but they do not directly address the problem of loss of appetite. 
Perhaps, utilizing drugs that target NTS neurotransmitters could 
to the anorectic effects of LPS (Faggioni et al., 1997; Lugarini 
et al., 2005). One of our studies also failed to observe increased 
c-fos expression in POMC neurons in response to LPS (Gautron 
et al., 2005). Likewise, no significant variation of expression for 
NPY, AgRP or POMC mRNA in the Arc of LPS-treated rodents 
using RNase protection assay or in situ hybridization were 
found (Turrin et al., 2001; Johnson et al., 2002; Gautron et al., 
2005). Finally, Reyes and Sawchenko (Reyes and Sawchenko, 
2002) demonstrated that IL-1-induced anorexia was not pre-
vented by chemical lesion of the Arc or the physical disruption 
of its projections.
If previous studies have not ﬁ  rmly established the role played 
by the melanocortin system in triggering anorexia during inﬂ  am-
mation, nevertheless they have suggested its modulatory role. For 
example, a recent study has evidenced that the immunoneutraliza-
tion of leptin attenuates LPS-induced anorexia in rats at 8 and 24 h 
after LPS (Sachot et al., 2004). This observation agrees with studies 
showing that inﬂ  ammatory anorexia due to LPS or turpentine is 
lowered whenever leptin falls, i.e., after food restriction (Lennie, 
1998; Gautron et al., 2005).
HEDONIC PATHWAYS
The regulation of the hedonic aspects of food intake (i.e., palat-
ability, reward) primarily involves the lateral hypothalamus and 
connected brain sites such as the nucleus accumbens and ventral 
tegmental area. The lateral hypothalamus uniquely contains a 
population of neurons expressing the neuropeptides orexins 
(Sakurai et al., 1998) which are well established to control arousal 
and stimulate feeding (Mieda et al., 2004). As expected, fasting 
is associated with increased c-fos in orexins neurons as well as 
up-regulated prepro-orexin mRNA expression (Sakurai et al., 
1998). One early study demonstrated that peripheral LPS reduces 
lateral hypothalamus auto-  stimulation in rats (Borowski et al., 
1998), suggesting that inﬂ  ammation results in the inhibition of 
this brain site. In agreement with such a view, we demonstrated 
that LPS suppressed c-fos expression in the lateral hypothalamus 
of fasted rats (Gautron et al., 2005). The previous study was fol-
lowed by other works showing that LPS speciﬁ  cally reduces c-fos 
expression in orexins neurons (Becskei et al., 2008; Park et al., 
2008; Gaykema and Goehler, 2009). The inhibition of orexins 
neurons in response to LPS is concomitant to the activation of 
nucleus accumbens neurons (Park et al., 2008), and it has been 
previously proposed that gabaergic neurons located in the ros-
tral nucleus accumbens produces anhedonia and reduction in 
motivated feeding by inhibiting orexins neurons (Kelley, 1999). 
It is therefore likely that the aforementioned circuitry is involved 
in LPS-induced anhedonia.
HOW TO STIMULATE APPETITE IN CHRONIC DISEASES?
ANTI-INFLAMMATORY APPROACHES
Many promising pharmacological agents have been clinically 
tested but, unfortunately, failed to demonstrate therapeutic efﬁ  -
cacy against anorexia or cachexia. Among other examples, endo-
cannabinoids showed limited effects in AIDS patients (Beal and 
Flynn, 1995) and no greater effect over placebo in advanced cancer 
patients (Strasser et al., 2006). Pharmacological agents currently 
in use to combat anorexia are thalidomide, eicosapentaenoic acid 
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be useful. For example, exendin-(9-39) which is an antagonist of 
GLP-1 receptor has been shown to attenuate LPS-induced ano-
rexia in rats (Grill et al., 2004).
STIMULATING OREXIGENIC PATHWAYS
A neurobiological roadmap of the mechanisms underlying anorexia 
is now available and, to effectively alleviate anorexia, it would be 
preferable to target neural circuits well known to be involved in the 
control of feeding. Thus far, the most promising strategy to attenu-
ate anorexia consists in modulating the melanocortin system by 
adjusting the circulating levels of endogenous or exogenous factors 
which are known to act on Arc neurons (Figure 1). We previously 
mentioned that the immunoneutralization of leptin, for instance, 
efﬁ  ciently attenuates LPS-induced anorexia in rats (Sachot et al., 
2004). Conversely, the administration of ghrelin, which stimulates 
NPY neurons, has given encouraging results in cancer patients 
(Neary et al., 2004; Wynne et al., 2005). The melanocortin system 
is not only regulated by hormones but also regulated by endogenous 
neurotransmitters. The stimulation of the serotonin   receptor 2C 
(5-HT2CR) in POMC neurons reduces feeding (Xu et al., 2008). 
While increased serotonergic neurotransmission is observed in 
LPS-treated animals (Dunn, 1992; MohanKumar et al., 1999; Nolan 
et al., 2000), interestingly, 5-HT2CR antagonists administration 
attenuates peripheral and central LPS-induced anorexia (von 
Meyenburg et al., 2003a,b; Asarian et al., 2007). Together, it suggests 
that modulating the signaling pathways of various hormones and 
neurotransmitters acting on Arc neurons can reduce anorexia.
Recent studies have shown that orexins neurons are inhibited 
in response to peripheral inﬂ  ammation (Gaykema and Goehler, 
2009), which is a remarkable observation given the role of the lat-
eral hypothalamus in regulating hedonic processes and the fact 
that cancer and AIDS patients often show anhedonia. Modaﬁ  nil, a 
psychostimulant which stimulates orexin neurons (Scammell et al., 
2000), has already been shown to diminish fatigue and improve 
quality of life in cancer patients (Blackhall et al., 2009; Spathis et al., 
2009). It would be interesting to further test the ability of this drug 
along with compounds that target speciﬁ  cally the orexinergic sys-
tem to reduce anorexia and anhedonia.
In conclusion, multiple factors and neural systems contribute 
to inﬂ  ammation-associated anorexia and no single intervention 
will sufﬁ  ce in order to reverse the neurochemical changes respon-
sible for anorexia in cancer and AIDS patients. Moreover, targeting 
the central nervous system is always complicated because of the 
blood-brain barrier and the lack of speciﬁ  city of many available 
  pharmacological agents. Nevertheless, the research on feeding 
behavior is permanently evolving, and new neural mechanisms 
are being regularly discovered, giving researchers opportunities to 
evaluate new therapeutics.
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